Tilray Brands (TLRY) Other Non-Current Liabilities (2019 - 2026)
Tilray Brands (TLRY) posted Other Non-Current Liabilities of $164000.0 for Q1 2026, down 60.67% on a QoQ basis from $417000.0 in Q4 2025.
Tilray Brands (TLRY) Other Non-Current Liabilities (2019 - 2026) Analysis & Trends
Tilray Brands' Other Non-Current Liabilities history runs 8 years deep, the most recent figure standing at $164000.0 for Q1 2026.
- Quarterly Other Non-Current Liabilities changed N/A year-over-year to $164000.0 in Q1 2026, while the trailing twelve-month figure through Feb 2026 was $164000.0 (changed N/A YoY) and the FY2025 annual result came in at $855000.0, up 850.0% from the prior year.
- Other Non-Current Liabilities was $164000.0 for Q1 2026 at Tilray Brands, down from $417000.0 in the prior quarter.
- Across five years, Other Non-Current Liabilities topped out at $13.0 million in Q3 2023 and bottomed at $17000.0 in Q4 2024.
- A 5-year average of $1.4 million and a median of $200500.0 in 2022 frame the typical range for Other Non-Current Liabilities.
- Annual changes were most pronounced in 2023 — Other Non-Current Liabilities surged 7162.57% — and 2024, when it tumbled 99.24%.
- Tilray Brands' Other Non-Current Liabilities stood at $185000.0 in 2022, then surged by 6927.03% to $13.0 million in 2023, then tumbled by 99.87% to $17000.0 in 2024, then surged by 2352.94% to $417000.0 in 2025, then sank by 60.67% to $164000.0 in 2026.
- Business Quant data shows TLRY's Other Non-Current Liabilities at $164000.0 in Q1 2026, $417000.0 in Q4 2025, and $855000.0 in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Tilray Brands | 465.02 Mn | 373.06 Mn | 54.95 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 164,000.00 |
| Nov 30, 2025 | 417,000.00 |
| May 31, 2025 | 855,000.00 |
| Nov 30, 2024 | 17,000.00 |
| Aug 31, 2024 | 99,000.00 |
| May 31, 2024 | 90,000.00 |
| Feb 29, 2024 | 210,000.00 |
| Aug 31, 2023 | 13.00 Mn |
| May 31, 2023 | 215,000.00 |
| Feb 28, 2023 | 3.34 Mn |
| Nov 30, 2022 | 185,000.00 |
| Aug 31, 2022 | 179,000.00 |
| May 31, 2022 | 191,000.00 |
| Feb 28, 2022 | 292,000.00 |
| Nov 30, 2021 | 320,000.00 |
| Aug 31, 2021 | 4.51 Mn |
| May 31, 2021 | 3.91 Mn |
| Mar 31, 2020 | 5.42 Mn |
| Dec 31, 2019 | 5.65 Mn |
| Mar 31, 2019 | 563,000.00 |